Theravance Biopharma Inc (TBPH)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN, CAYMAN ISLANDS KY1-1104

Theravance Biopharma Inc focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, and central nervous system.

Data as of 2020-11-22
Market Cap1.101 Billion Shares Outstanding63.981 Million Avg 30-day Volume356.105 Thousand
P/E Ratio-3.6 Dividend Yield EPS-4.73
Price/Sales13.327 Price cash flow ratio Price free cash flow ratio-4.3
Book Value-4.09 Price to Tangible Book-4.21 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.104883
BETA1.14802 52-week High/Low31.54 / 14.48 Stddev0.149381
View SEC Filings from TBPH instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 1 -100.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 116 124 -6.45% 38 (2.5%) 37 (2.4%) 2.7%
13F shares: 51.38 Million 51.67 Million -0.56% 25.29 Million 22.321 Million 13.3%
% Ownership 80.3358 81.9013 -1.91% 39.5421 35.3805 11.76%
New Positions: 12 35 -65.71% 6 16 -62.5%
Increased Positions 35 41 -14.63% 13 12 8.33%
Closed Positions 18 13 38.46% 4 4 0.0%
Reduced Positions 50 28 78.57% 17 5 240.0%
Total Calls 56.43 Thousand 217 25904.61% 30 Thousand
Total Puts 70.202 Thousand 48.405 Thousand 45.03% 30 Thousand 21 Thousand 42.86%
PUT/CALL Ratio 1.24 223.06 -99.44% 1.0 -99.55%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TBPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TBPH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GRAHAM RICHARD A SVP, DEVELOPMENT

  • Officer
135,125 2020-09-01 3

WINNINGHAM RICK E CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,381,682 2020-08-20 4

HAUMANN BRETT K CHIEF MEDICAL OFFICER

  • Officer
282,810 2020-08-20 4

PASQUALONE FRANK SVP, CHIEF COMM OPS OFFICER

  • Officer
405,894 2020-08-20 4

SHAFER BRADFORD J EVP, GEN. COUNSEL, SECRETARY

  • Officer
256,723 2020-08-20 4

WORBOYS PHILIP D SVP, RESEARCH & TRANSL SCIENCE

  • Officer
328,448 2020-08-20 4

PITZER KENNETH R SVP, PROD STRAT & COMM PLNG

  • Officer
340,087 2020-08-20 4

SABESAN VIJAY SVP, TECHNICAL OPERATIONS

  • Officer
196,842 2020-08-20 5

BRADY ANN PRESIDENT, TBIL

  • Officer
100,579 2020-08-20 4

HINDMAN ANDREW A. SVP, CHIEF FINANCIAL OFFICER

  • Officer
123,135 2020-08-20 4

PAKIANATHAN DEEPIKA

  • Director
0 2020-07-01 2

GLAXOSMITHKLINE PLC

  • 10% Owner
0 2020-06-22 1

GUNDERSON ROBERT V JR

  • Director
69,112 2020-04-28 1

MALKIEL BURTON G

  • Director
86,777 2020-04-28 1

WHITESIDES GEORGE M

  • Director
239,248 2020-04-28 1

YOUNG WILLIAM D

  • Director
58,330 2020-04-28 1

MITCHELL DEAN J

  • Director
41,206 2020-04-28 1

BROSHY ERAN

  • Director
41,206 2020-04-28 1

MOLINEAUX SUSAN

  • Director
41,206 2020-04-28 1

O'CONNOR DONAL

  • Director
34,206 2020-04-28 1

SMALDONE ALSUP LAURIE

  • Director
24,982 2020-04-28 1

HEGDE SHARATHCHANDRA S SVP, RESEARCH

  • Officer
259,900 2019-08-20 0

RINGROSE PETER S

  • Director
37,999 2019-04-30 0

SULIMAN SHEHNAAZ SVP, CORP DEV & STRATEGY

  • Officer
97,198 2019-02-20 0

GALA RENEE D SVP, CHIEF FINANCIAL OFFICER

  • Officer
157,657 2018-11-20 0

FORE HENRIETTA

  • Director
24,000 2017-08-11 0

LEE JUNNING SR. VP, TECHNICAL OPERATIONS

  • Officer
234,071 2017-02-20 0

MAMMEN MATHAI SVP, RESEARCH & DEVELOPMENT

  • Officer
288,111 2016-03-15 0

BLUM LEONARD M SR VP, CHIEF COMM. OFFICER

  • Officer
182,731 2016-02-20 0

JONKER JEFFREY DAVID SENIOR VP, CORP. & BUS. DEV.

  • Officer
0 2014-06-03 0

ATIEH MICHAEL G

  • Director
0 2014-06-03 0

THERAVANCE INC

  • 10% Owner
0 2014-05-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments